Serengeti Asset Management LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
Serengeti Asset Management LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,509,000
-39.5%
15,000
-40.0%
0.05%
-95.2%
Q1 2021$2,493,000
-19.3%
25,0000.0%1.09%
+8.4%
Q4 2020$3,090,000
+13.3%
25,000
-10.7%
1.01%
+18.0%
Q3 2020$2,728,000
+249.7%
28,000
+460.0%
0.85%
+211.7%
Q2 2020$780,000
-64.0%
5,000
-66.7%
0.27%
-87.8%
Q1 2020$2,165,00015,0002.25%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders